Skip to Content

Invenomic Investor BIVRX

Medalist Rating as of | See Invenomic Investment Hub
  • NAV / 1-Day Return 18.31  /  −1.19 %
  • Total Assets 1.4 Bil
  • Adj. Expense Ratio
    2.480%
  • Expense Ratio 3.330%
  • Distribution Fee Level High
  • Share Class Type No Load
  • Category Long-Short Equity
  • Investment Style Mid Value
  • Min. Initial Investment 5,000
  • Status Limited
  • TTM Yield 2.36%
  • Turnover 140%

USD | NAV as of Apr 23, 2024 | 1-Day Return as of Apr 23, 2024, 10:14 PM GMT+0

Morningstar’s Analysis BIVRX

Will BIVRX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin Invenomic Investor's Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BIVRX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 23.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Us Dollar Broker

71.67 1.0 Bil
Cash and Equivalents

First American Government Obligs X

8.47 121.4 Mil
Cash and Equivalents

AT&T Inc

3.15 45.2 Mil
Communication Services

Zoom Video Communications Inc

3.08 44.1 Mil
Technology

Viatris Inc

3.03 43.4 Mil
Healthcare

eBay Inc

2.61 37.4 Mil
Consumer Cyclical

PayPal Holdings Inc

2.25 32.3 Mil
Financial Services

Chord Energy Corp Ordinary Shares - New

2.01 28.8 Mil
Energy

Clarivate PLC Ordinary Shares

1.99 28.6 Mil
Technology

PENN Entertainment Inc

1.91 27.3 Mil
Consumer Cyclical